Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.81%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 12.64Close
$ 5.31 - $ 12.64 52-Week Range
Ticker Information
Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQREGENXBIO INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RGNX - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.82M | 1.81% | $ 155.78M |
| 3/31/2025 | $ 2.9M | 1.85% | $ 156.72M |
| 12/31/2024 | $ 2.44M | 2.92% | $ 83.33M |
| 9/30/2024 | $ 2.48M | 2.94% | $ 84.33M |
| 6/30/2024 | $ 3.6M | 4.04% | $ 89.04M |
| 3/31/2024 | $ 5.7M | 6.57% | $ 86.73M |
| 12/31/2023 | $ 9.96M | 11.04% | $ 90.24M |
| 9/30/2023 | $ 14.3M | 14.39% | $ 99.37M |
| 6/30/2023 | $ 17.91M | 18.47% | $ 96.97M |
| 3/31/2023 | $ 24.57M | 22.41% | $ 109.64M |
Key Performance Insights, Last 5 Years
- REGENXBIO INC's latest trailing twelve months (TTM) CapEx % stands at 10.36%.
- Over the past 5 years, REGENXBIO INC's average CapEx % has been 17.91%.
- The median CapEx % for REGENXBIO INC during this period was 12.29%
- REGENXBIO INC reached its highest CapEx % over the past 5 years at 88.53%.
- The lowest CapEx % recorded by REGENXBIO INC in the same timeframe 1.81%
REGENXBIO INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for REGENXBIO INC is calculated as follows: CapEx [ $ 15.01M ] / Revenues [ $ 144.89M ]
(=) CapEx % [ 10.36% ] RGNX - Capital Expenditures Margin, Last 5 years
1.81%
Minimum
Jun 30, 2025
88.53%
Maximum
Sep 30, 2021
17.91%
Average
12.29%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |